Table 3. Identified compounds that change significantly after atenolol treatment in Caucasians and African Americans (n = 272).
| Compound | % change | p-value | Q value |
| oleic acid (18∶1 cis-9) | −17.1 | 1.18E-07 | 5.43E-05 |
| linoleic acid (18∶2 n-6) | −12.8 | 1.06E-06 | 2.44E-04 |
| palmitoleic acid (16∶1) | −15.4 | 2.51E-05 | 3.85E-03 |
| palmitic acid (16∶0) | −9.1 | 3.42E-05 | 3.93E-03 |
| 3-hydroxybutanoic acid | −16.4 | 4.268E-05 | 3.93E-03 |
| arachidonic acid (20∶4 ω-6) | −9.5 | 4.33E-04 | 0.031 |
| threitol | 6.6 | 4.67E-04 | 0.031 |
| methylhexadecanoic acid (17∶0) | −7.4 | 6.16E-04 | 0.035 |
| alpha ketoglutaric acid | 9.4 | 9.26E-04 | 0.046 |
| myristic acid (14∶0) | −4.1 | 7.95E-03 | 0.247 |
| threonine | −7.1 | 8.30E-03 | 0.247 |
| arabitol | 4.0 | 8.57E-03 | 0.247 |
| stearic acid (18∶0) | −8.1 | 0.015 | 0.295 |
| dihydroabietic acid | 5.1 | 0.031 | 0.474 |
| glycerol-alpha-phosphate | −7.1 | 0.041 | 0.528 |
| conduritol-beta-epoxide* | 6.8 | 0.044 | 0.528 |
| allo-inositol | 5.5 | 0.049 | 0.574 |
Bold line indicates Q<0.05.